Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayato Tada

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Journal of Atherosclerosis and Thrombosis|February 8, 2021
Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery DiseaseHayato Tada
Journal of Atherosclerosis and Thrombosis|January 28, 2026
The Mysterious Question on Discordance between Achilles Tendon Thickness Assessed by Ultrasound and X-ray Has been SolvedHayato Tada
Atherosclerosis|June 29, 2024
Toward personalized medicine in patients with familial hypercholesterolemiaHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|February 18, 2024
Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 15, 2024
A fascinating association between HDL as a multi-potent particle and hypertensionHayato Tada, Masayuki Takamura
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2026
Unanswered Questions About the Relationship Between Lipoprotein(a) and Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 13, 2022
Seeing is believing: Visualization of multivariable risk modelsKenichi Nakajima, Hayato Tada
Journal of Atherosclerosis and Thrombosis|July 27, 2022
Finding Clues to Protect Against Coronary Atherosclerosis via Traditional Risk FactorsHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|March 29, 2026
An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering TherapyHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|May 10, 2026
It's Time to Measure Lp(a): Recognizing a Neglected Cardiovascular RiskHayato Tada, Masayuki Takamura
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Journal of Atherosclerosis and Thrombosis|February 8, 2021
Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery DiseaseHayato Tada
Journal of Atherosclerosis and Thrombosis|January 28, 2026
The Mysterious Question on Discordance between Achilles Tendon Thickness Assessed by Ultrasound and X-ray Has been SolvedHayato Tada
Atherosclerosis|June 29, 2024
Toward personalized medicine in patients with familial hypercholesterolemiaHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|February 18, 2024
Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 15, 2024
A fascinating association between HDL as a multi-potent particle and hypertensionHayato Tada, Masayuki Takamura
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2026
Unanswered Questions About the Relationship Between Lipoprotein(a) and Atherosclerotic Cardiovascular DiseaseHayato Tada, Masayuki Takamura
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 13, 2022
Seeing is believing: Visualization of multivariable risk modelsKenichi Nakajima, Hayato Tada
Journal of Atherosclerosis and Thrombosis|July 27, 2022
Finding Clues to Protect Against Coronary Atherosclerosis via Traditional Risk FactorsHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|March 29, 2026
An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering TherapyHayato Tada, Masayuki Takamura
Journal of Atherosclerosis and Thrombosis|May 10, 2026
It's Time to Measure Lp(a): Recognizing a Neglected Cardiovascular RiskHayato Tada, Masayuki Takamura
Pageof 31